Related Experiment Video
Updated: May 21, 2026

Using a Chemical Biopsy for Graft Quality Assessment
Published on: June 17, 2020
Kidney biopsy in patients with glomerulonephritis: is the earlier the better?
Dominik G Haider1, Alexander Friedl, Slobodan Peric
1Department of Nephrology and Dialysis, University Hospital Vienna, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. dominik.haider@meduniwien.ac.at
Insights
Early histological diagnosis of glomerulonephritis (GN) in chronic kidney disease (CKD) stages 1 and 2 is linked to better outcomes. Diagnosing GN before significant kidney function decline improves patient prognosis and treatment effectiveness.
Area of Science:
- Nephrology
- Immunology
- Internal Medicine
Background:
- Histological diagnosis is recommended for kidney diseases to aid risk stratification.
- The optimal timing for kidney disease histological diagnosis remains unevaluated.
- This study investigates the impact of early vs. late glomerulonephritis (GN) diagnosis on patient outcomes.
Purpose of the Study:
- To determine if early histological diagnosis of GN in chronic kidney disease (CKD) is associated with different outcomes compared to diagnosis at later stages.
- To evaluate the association between kidney function at the time of GN diagnosis and clinical outcomes.
Main Methods:
- Retrospective analysis of 424 patients with histological GN diagnosis.
- Kidney function assessed by estimated glomerular filtration rate (eGFR) at biopsy and post-treatment.
- Outcomes included death, dialysis, transplantation, or CKD stage progression.
Main Results:
- GFR and CKD stage at biopsy significantly predicted adverse outcomes (death, dialysis, transplantation, or progression).
- Patients diagnosed with GN at CKD stages 1 and 2 experienced fewer adverse events.
- Early diagnosis (CKD stages 1-2) showed significantly better outcomes than diagnosis with eGFR <60 ml/min.
Conclusions:
- Kidney function at the time of histological GN diagnosis correlates with clinical outcomes.
- Early diagnosis and treatment initiation before substantial renal impairment are crucial for optimal therapeutic benefit in GN.
- Timely histological diagnosis enables risk stratification and personalized treatment strategies for improved patient prognosis.
Background:
Interventional diagnostic procedures are established for several diseases in medicine. Despite the KDOQI guideline recommendation for histological diagnosis of kidney disease to enable risk stratification, its optimal time point has not been evaluated. We have therefore analyzed whether histological diagnosis of glomerulonephritis (GN) at an early stage of chronic kidney disease (CKD) is associated with different outcome compared to diagnosis at a more advanced stage.
Methods:
A cohort of 424 consecutive patients with histological diagnosis of GN were included in a retrospective data analysis. Kidney function was assessed by glomerular filtration rate (GFR) estimation at the time point of kidney biopsy and after consecutive immunosuppressive therapy. Censored events were death, initiation of dialysis or kidney transplantation, or progression of disease, defined as deterioration of CKD stage ≥ 1 from kidney biopsy to last available kidney function measurement.
Results:
Occurrence of death, dialysis/transplantation or progression of disease were associated with GFR and CKD stage at the time of kidney biopsy (p < 0.001 for all). Patients with CKD stage 1 and 2 at kidney biopsy had fewer endpoints compared to patients with a GFR of <60 ml/min (p < 0.001).
Conclusion:
Kidney function at the time point of histological GN diagnosis is associated with clinical outcome, likely due to early initiation of specific drug treatment. This suggests that selection of therapy yields greatest benefit before renal function is impaired in GN.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury III: Clinical Manifestations
Kidney Transplant II: Surgical Procedure
Kidney Transplant I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Kidney Transplant III: Nursing Management
